Aurora Cannabis Inc. (ACB.TO) (TSE:ACB) Director Michael Singer Sells 25,000 Shares

Aurora Cannabis Inc. (ACB.TO) (TSE:ACB) Director Michael Singer sold 25,000 shares of the stock in a transaction that occurred on Friday, February 19th. The stock was sold at an average price of C$15.58, for a total value of C$389,500.00. Following the completion of the transaction, the director now directly owns 1,777 shares of the company’s stock, valued at C$27,685.66.

ACB traded down C$1.10 during trading on Tuesday, hitting C$13.73. The company had a trading volume of 2,557,495 shares, compared to its average volume of 6,631,091. The company has a market capitalization of C$2.71 billion and a PE ratio of -0.77. The firm’s 50-day moving average price is C$15.10 and its 200 day moving average price is C$11.32. The company has a quick ratio of 3.11, a current ratio of 4.96 and a debt-to-equity ratio of 22.46. Aurora Cannabis Inc. has a one year low of C$4.93 and a one year high of C$26.79.

A number of brokerages have recently issued reports on ACB. CIBC increased their target price on Aurora Cannabis Inc. (ACB.TO) to C$18.50 and gave the stock an “underperform” rating in a report on Tuesday, February 16th. Jefferies Financial Group dropped their price objective on Aurora Cannabis Inc. (ACB.TO) from C$6.90 to C$4.93 and set an “underperform” rating for the company in a report on Monday, November 16th. Atb Cap Markets raised Aurora Cannabis Inc. (ACB.TO) from an “underperform” rating to a “sector perform” rating in a research note on Monday, November 16th. Stifel Nicolaus boosted their price objective on shares of Aurora Cannabis Inc. (ACB.TO) from C$6.50 to C$7.80 in a report on Friday, February 12th. Finally, Canaccord Genuity upped their target price on shares of Aurora Cannabis Inc. (ACB.TO) from C$11.00 to C$14.00 in a research note on Friday, February 12th. Three investment analysts have rated the stock with a sell rating and five have given a hold rating to the company’s stock. Aurora Cannabis Inc. (ACB.TO) has a consensus rating of “Hold” and an average target price of C$11.46.

Aurora Cannabis Inc. (ACB.TO) Company Profile

Aurora Cannabis Inc produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Story: If I purchase shares through a brokerage account, am I the holder of record?

Receive News & Ratings for Aurora Cannabis Inc. (ACB.TO) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis Inc. (ACB.TO) and related companies with's FREE daily email newsletter.